全文获取类型
收费全文 | 1032篇 |
免费 | 81篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 52篇 |
妇产科学 | 13篇 |
基础医学 | 121篇 |
口腔科学 | 31篇 |
临床医学 | 97篇 |
内科学 | 304篇 |
皮肤病学 | 20篇 |
神经病学 | 54篇 |
特种医学 | 138篇 |
外科学 | 118篇 |
综合类 | 18篇 |
预防医学 | 20篇 |
眼科学 | 3篇 |
药学 | 47篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 5篇 |
2022年 | 8篇 |
2021年 | 17篇 |
2020年 | 14篇 |
2019年 | 21篇 |
2018年 | 28篇 |
2017年 | 16篇 |
2016年 | 19篇 |
2015年 | 28篇 |
2014年 | 25篇 |
2013年 | 47篇 |
2012年 | 63篇 |
2011年 | 54篇 |
2010年 | 65篇 |
2009年 | 46篇 |
2008年 | 47篇 |
2007年 | 52篇 |
2006年 | 34篇 |
2005年 | 36篇 |
2004年 | 30篇 |
2003年 | 41篇 |
2002年 | 22篇 |
2001年 | 23篇 |
2000年 | 14篇 |
1999年 | 20篇 |
1998年 | 32篇 |
1997年 | 40篇 |
1996年 | 40篇 |
1995年 | 29篇 |
1994年 | 19篇 |
1993年 | 18篇 |
1992年 | 14篇 |
1991年 | 4篇 |
1990年 | 7篇 |
1989年 | 14篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1967年 | 2篇 |
排序方式: 共有1120条查询结果,搜索用时 15 毫秒
31.
Castagna L Bertuzzi A Nozza A Siracusano L Balzarotti M Magagnoli M Sarina B Timofeeva I Sinnone M Grimoldi MG Farè M Santoro A 《Bone marrow transplantation》2002,30(4):207-214
The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 x 10(9)/l and an untransfused platelet count of more than 20 x 10(9)/l was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62% of evaluable patients (grade II/B or III/C 80%) responsive to steroids. Extensive chronic GVHD was observed in 62% of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25%). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients. 相似文献
32.
Arvind K Sharma Shadi M Hamwi Nidhi Garg Marco T Castagna William Suddath Samer Ellahham Joseph Lindsay 《Catheterization and cardiovascular interventions》2002,56(3):346-352
Cocaine-associated myocardial infarction (CAMI) is a well-reported entity. Most previous reports on CAMI have been limited to conservative care utilizing benzodiazepines, aspirin, nitroglycerin, calcium channel blockers, and thrombolytics. Current guidelines on CAMI advocate immediate use of angiography and angioplasty if available rather than routine administration of thrombolytics. However, based on literature search from 1966 to 2001 (using keywords "cocaine," "myocardial infarction," and "angioplasty"), there have been only two case reports of percutaneous coronary intervention (PCI) in patients with cocaine-associated myocardial infarction. Both were notable for complications either during or immediately after the procedure. We report a series of 10 patients with cocaine-associated myocardial infarction who were treated with percutaneous interventions, which included angioplasty, stenting, and AngioJet mechanical extraction of thrombus. Despite the different arteriopathic process involved, our findings suggest that PCI can be performed safely and with a high degree of procedural success in patients with CAMI. 相似文献
33.
34.
Rosa Paula Biscolla Clara Ugolini Mariangela Sculli Valeria Bottici Maria Grazia Castagna Cristina Romei Barbara Cosci Eleonora Molinaro Pinuccia Faviana Fulvio Basolo Paolo Miccoli Furio Pacini Aldo Pinchera Rossella Elisei 《Thyroid》2004,14(11):946-952
Papillary thyroid microcarcinoma (mPTC), is a very frequent incidental finding with a frequency varying from a few percent to 35% at postmortem histopathologic examinations. However, the presence of mPTC in patients undergoing thyroidectomy for multinodular goiter (MNG) and for Graves' disease (GD) has been found to be lower. Patients with medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) association have been published as anecdotal case reports, as well as kindred with familial MTC or multiple endocrine neoplasia (MEN) 2A with some members simultaneously affected by MTC and PTC. We studied the prevalence and the biological behavior of MTC associated with PTC, with particular attention to those cases in which a mPTC was incidentally found. Twenty-seven of 196 (13.8%) MTC cases showed an association with PTC and in particular 21 of 190 (11.05%) with an incidental mPTC. This percentage is higher than that reported in the literature on the association of mPTC with GD (2.8%-4.5%) and MNG (3%). Also the percentage of the more general association of MTC/PTC, not restricted to mPTC, found in our series (13.8%) is higher than that reported in studies that analyzed the prevalence of PTC (any size) in patients treated for MNG (7.5%). A similarly high percentage of MTC/PTC had not been reported before and in particular there are no reports on large series of MTC/PTC. We also analyzed the epidemiologic, clinical, and pathologic features of MTC associated and not associated with PTC without finding any difference. In particular the outcome of the MTC did not appear to be influenced by the presence of the PTC and the specific radioiodine treatments. Moreover, although we cannot completely exclude a shared pathogenic event as the cause of both MTC and PTC, the molecular analysis of RET gene alterations did not show any common mutation. 相似文献
35.
36.
Impact of intranasal sodium hyaluronate on the short‐term quality of life of patients undergoing functional endoscopic sinus surgery for chronic rhinosinusitis
下载免费PDF全文
![点击此处可从《International forum of allergy & rhinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
37.
A Mocroft B Neesgard R Zangerle A Rieger A Castagna V Spagnuolo A Antinori FC Lampe M Youle JJ Vehreschild C Mussini V Borghi J Begovac C Duvivier HF Gunthard A Rauch J Tiraboschi N Chkhartishvili N Bolokadze F Wit JC Wasmuth S De Wit C Necsoi C Pradier V Svedhem C Stephan K Petoumenos H Garges F Rogatto L Peters L Ryom 《HIV medicine》2020,21(9):599-606
38.
Schmid C Labopin M Nagler A Niederwieser D Castagna L Tabrizi R Stadler M Kuball J Cornelissen J Vorlicek J Socié G Falda M Vindeløv L Ljungman P Jackson G Kröger N Rank A Polge E Rocha V Mohty M;Acute Leukaemia Working Party of the European Group for Blood Marrow Transplantation 《Blood》2012,119(6):1599-1606
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cell transplantation (HSCT) with reduced intensity conditioning (RIC) is scarce, a retrospective registry study was performed by the Acute Leukemia Working Party of EBMT. Among 2815 RIC transplants performed for AML in complete remission (CR) between 1999 and 2008, cumulative incidence of relapse was 32% ± 1%. Relapsed patients (263) were included into a detailed analysis of risk factors for overall survival (OS) and building of a prognostic score. CR was reinduced in 32%; remission duration after transplantation was the only prognostic factor for response (P = .003). Estimated 2-year OS from relapse was 14%, thereby resembling results of AML relapse after standard conditioning. Among variables available at the time of relapse, remission after HSCT > 5 months (hazard ratio [HR] = 0.50, 95% confidence interval [CI], 0.37-0.67, P < .001), bone marrow blasts less than 27% (HR = 0.53, 95% CI, 0.40-0.72, P < .001), and absence of acute GVHD after HSCT (HR = 0.67, 95% CI, 0.49-0.93, P = .017) were associated with better OS. Based on these factors, 3 prognostic groups could be discriminated, showing OS of 32% ± 7%, 19% ± 4%, and 4% ± 2% at 2 years (P < .0001). Long-term survival was achieved almost exclusively after successful induction of CR by cytoreductive therapy, followed either by donor lymphocyte infusion or second HSCT for consolidation. 相似文献
39.
El-Cheikh J Crocchiolo R Boher JM Furst S Stoppa AM Ladaique P Faucher C Calmels B Castagna L Lemarie C De Colella JM Coso D Bouabdallah R Chabannon C Blaise D 《European journal of haematology》2012,88(6):497-503
The purpose of this study was to assess the results of allogeneic stem cell transplantation (allo-SCT) after reduced-intensity conditioning (RIC) from matched related donors (MRD) and unrelated donors (URD) in 40 patients with high-risk multiple myeloma (MM) in a single centre. Seventeen (43%) (Group 1) and 23 patients (57%) (Group 2) had URD and MRD, respectively. Thirty-nine patients (98%) received one or more autologous transplantation. The median follow-up was 22 months (1-49). None of our patient experienced a graft rejection. The cumulative incidence of grade II-IV acute GVHD was higher (47%) for the URD vs. (17%) for the MRD (P = 0.092). The cumulative incidence of chronic GVHD was no different between the two groups (24% vs. 30%, respectively). At 2 yr, the TRM probabilities were lower in the unrelated group 12% vs. 22% in the related group (P = 0.4). Also at 2 yrs, for patients receiving unrelated transplantation overall and progression-free survivals, 59% and 42%, respectively compared to patients with related donor transplantation, 66% and 44% (P = 0.241). In conclusion, these results suggest that URD in MM is feasible. The small number of patients with URD emphasizes the need to delineate indications and perform prospective protocols. 相似文献